Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Neuropharmacology
|
July 19, 2022
The potent α<sub>2</sub>-adrenoceptor antagonist RS 79948 also inhibits dopamine D<sub>2</sub> -receptors: Comparison with atipamezole and raclopride
Roberto Frau, Paola Devoto, Sonia Aroni, et al.
Investigational New Drugs
|
October 18, 2025
Synergistic combination of the adrenergic antagonist SR59230A with common chemotherapeutic drugs and target therapies in cancer and endothelial cells
Arianna Bandini, Letizia Biso, Cristina Viaggi, et al.
Sensors (Basel, Switzerland)
|
July 28, 2022
Virtual Reality for Shoulder Rehabilitation: Accuracy Evaluation of Oculus Quest 2
Arianna Carnevale, Ilaria Mannocchi, Mohamed Saifeddine Hadj Sassi, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 3, 2021
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli, Shivakumar Kolachalam, Biancamaria Longoni, et al.
Current Neuropharmacology
|
August 20, 2020
Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?
Marco Carli, Stefano Aringhieri, Shivakumar Kolachalam, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 29, 2023
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center
Letizia Biso, Marco Carli, Shivakumar Kolachalam, et al.
Expert Review of Neurotherapeutics
|
June 25, 2024
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder
Giulio Emilio Brancati, Anna Magnesa, Donatella Acierno, et al.
Pharmacology & Therapeutics
|
June 29, 2018
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Stefano Aringhieri, Marco Carli, Shivakumar Kolachalam, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
January 13, 2023
Long-term treatment of adult ADHD in a naturalistic setting: Clinical predictors of attrition, medication choice, improvement, and response
Giulio Emilio Brancati, Francesco De Dominicis, Alessandra Petrucci, et al.
Molecular and Cellular Endocrinology
|
June 5, 2024
Dopamine-mediated autocrine inhibition of insulin secretion
Edoardo Ferrero, Matilde Masini, Marco Carli, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Neuropharmacology
|
July 19, 2022
The potent α<sub>2</sub>-adrenoceptor antagonist RS 79948 also inhibits dopamine D<sub>2</sub> -receptors: Comparison with atipamezole and raclopride
Roberto Frau, Paola Devoto, Sonia Aroni, et al.
Investigational New Drugs
|
October 18, 2025
Synergistic combination of the adrenergic antagonist SR59230A with common chemotherapeutic drugs and target therapies in cancer and endothelial cells
Arianna Bandini, Letizia Biso, Cristina Viaggi, et al.
Sensors (Basel, Switzerland)
|
July 28, 2022
Virtual Reality for Shoulder Rehabilitation: Accuracy Evaluation of Oculus Quest 2
Arianna Carnevale, Ilaria Mannocchi, Mohamed Saifeddine Hadj Sassi, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 3, 2021
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli, Shivakumar Kolachalam, Biancamaria Longoni, et al.
Current Neuropharmacology
|
August 20, 2020
Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?
Marco Carli, Stefano Aringhieri, Shivakumar Kolachalam, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 29, 2023
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center
Letizia Biso, Marco Carli, Shivakumar Kolachalam, et al.
Expert Review of Neurotherapeutics
|
June 25, 2024
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder
Giulio Emilio Brancati, Anna Magnesa, Donatella Acierno, et al.
Pharmacology & Therapeutics
|
June 29, 2018
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Stefano Aringhieri, Marco Carli, Shivakumar Kolachalam, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
January 13, 2023
Long-term treatment of adult ADHD in a naturalistic setting: Clinical predictors of attrition, medication choice, improvement, and response
Giulio Emilio Brancati, Francesco De Dominicis, Alessandra Petrucci, et al.
Molecular and Cellular Endocrinology
|
June 5, 2024
Dopamine-mediated autocrine inhibition of insulin secretion
Edoardo Ferrero, Matilde Masini, Marco Carli, et al.
Page
of 6